Attached files
| file | filename |
|---|---|
| EX-32 - EX-32.1 - Evofem Biosciences, Inc. | neot-ex321_201503318.htm |
| EX-31 - EX-31.1 - Evofem Biosciences, Inc. | neot-ex311_201503316.htm |
| EX-31 - EX-31.2 - Evofem Biosciences, Inc. | neot-ex312_201503317.htm |
| EXCEL - IDEA: XBRL DOCUMENT - Evofem Biosciences, Inc. | Financial_Report.xls |
| 10-Q - FORM 10-Q - Evofem Biosciences, Inc. | neot-10q_20150331.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Neothetics, Inc. (the “Company”) on Form 10-Q for the period ending March 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: May 14, 2015 |
|
By: |
/s/ Susan A. Knudson |
|
|
|
|
Susan A. Knudson |
|
|
|
|
Chief Financial Officer and Secretary (Principal Financial and Accounting Officer) |
The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of the Report or as a separate document.